Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hunsmann

Showing results (231-240 of 257) with videos related to

Pageof 26
Sort By:
Klinische Wochenschrift|March 1, 1985
Seroepidemiology of HTLV-III (LAV) in the Federal Republic of GermanyG Hunsmann, J Schneider, H Bayer, et al.
AIDS (London, England)|March 28, 1998
A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32HH Petry, C Stahl-Hennig, U Dittmer, et al.
Haematology and Blood Transfusion|January 1, 1987
LAV/HTLV-III: fine-structure analysis, localization of structural proteins, and detection of envelope antigens by patient seraG Pauli, E Hausmann, R Weiss, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Prechallenge high neutralizing antibodies and long-lasting immune reactivity to gp41 correlate with protection of rhesus monkeys against productive simian immunodeficiency virus infection or disease developmentH Petry, U Dittmer, D Jones, et al.
Medical Microbiology and Immunology|October 1, 1995
Follicular dendritic cells productively infected with immunodeficiency viruses transmit infection to T cellsR Sprenger, K M Toellner, C Schmetz, et al.
Medical Microbiology and Immunology|January 1, 1984
Antibodies to ATLV/HTLV-1 in AfricaG Hunsmann, H Bayer, J Schneider, et al.
Medical Microbiology and Immunology|January 1, 1977
Immuno-prophylaxis and -therapy of C-type oncorna viral diseases in mice and catsW Schäfer, D P Bolognesi, F de Noronha, et al.
Gene|April 25, 2000
Differences in HERV-K LTR insertions in orthologous loci of humans and great apesY B Lebedev, O S Belonovitch, N V Zybrova, et al.
AIDS (London, England)|June 1, 1993
Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virusC Stahl-Hennig, G Voss, U Dittmer, et al.
Virology|February 15, 1996
Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derived ex vivoW Luke, C Coulibaly, U Dittmer, et al.
Pageof 26

Showing results (231-240 of 257) with videos related to

Sort By:
Pageof 26
Klinische Wochenschrift|March 1, 1985
Seroepidemiology of HTLV-III (LAV) in the Federal Republic of GermanyG Hunsmann, J Schneider, H Bayer, et al.
AIDS (London, England)|March 28, 1998
A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32HH Petry, C Stahl-Hennig, U Dittmer, et al.
Haematology and Blood Transfusion|January 1, 1987
LAV/HTLV-III: fine-structure analysis, localization of structural proteins, and detection of envelope antigens by patient seraG Pauli, E Hausmann, R Weiss, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 22, 1998
Prechallenge high neutralizing antibodies and long-lasting immune reactivity to gp41 correlate with protection of rhesus monkeys against productive simian immunodeficiency virus infection or disease developmentH Petry, U Dittmer, D Jones, et al.
Medical Microbiology and Immunology|October 1, 1995
Follicular dendritic cells productively infected with immunodeficiency viruses transmit infection to T cellsR Sprenger, K M Toellner, C Schmetz, et al.
Medical Microbiology and Immunology|January 1, 1984
Antibodies to ATLV/HTLV-1 in AfricaG Hunsmann, H Bayer, J Schneider, et al.
Medical Microbiology and Immunology|January 1, 1977
Immuno-prophylaxis and -therapy of C-type oncorna viral diseases in mice and catsW Schäfer, D P Bolognesi, F de Noronha, et al.
Gene|April 25, 2000
Differences in HERV-K LTR insertions in orthologous loci of humans and great apesY B Lebedev, O S Belonovitch, N V Zybrova, et al.
AIDS (London, England)|June 1, 1993
Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virusC Stahl-Hennig, G Voss, U Dittmer, et al.
Virology|February 15, 1996
Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derived ex vivoW Luke, C Coulibaly, U Dittmer, et al.
Pageof 26